Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/198672
Title: | MLH1-methylated endometrial cancer under 60 years of age as the “sentinel” cancer in female carriers of high-risk constitutional MLH1 epimutation |
Author: | Hitchins, Megan P. Álvarez, Rocío Zhou, Lisa Aguirre, Francesca Dámaso, Estela Pineda Riu, Marta Capella, Gabriel Wong, Justin J.- L. Yuan, Xiaopu Ryan, Shawnia R. Sathe, Devika S. Baxter, Melanie D. Cannon, Timothy Biswas, Rakesh Demarco, Tiffani Grzelak, Doreen Hampel, Heather Pearlman, Rachel |
Keywords: | Càncer d'endometri Medicina experimental Endometrial cancer Experimental medicine |
Issue Date: | 1-Apr-2023 |
Publisher: | Elsevier |
Abstract: | Objective. Universal screening of endometrial carcinoma (EC) for mismatch repair deficiency (MMRd) and Lynch syndrome uses presence of MLH1 methylation to omit common sporadic cases from follow-up germline testing. However, this overlooks rare cases with high-risk constitutional MLH1 methylation (epimutation), a poorly-recognized mechanism that predisposes to Lynch-type cancers with MLH1 methylation. We aimed to de-termine the role and frequency of constitutional MLH1 methylation among EC cases with MMRd, MLH1- methylated tumors.Methods. We screened blood for constitutional MLH1 methylation using pyrosequencing and real-time methylation-specific PCR in patients with MMRd, MLH1-methylated EC ascertained from (i) cancer clinics (n = 4, <60 years), and (ii) two population-based cohorts; Columbus-area (n = 68, all ages) and Ohio Colo-rectal Cancer Prevention Initiative (OCCPI) (n = 24, <60 years).Results. Constitutional MLH1 methylation was identified in three out of four patients diagnosed between 36 and 59 years from cancer clinics. Two had mono-/hemiallelic epimutation (similar to 50% alleles methylated). One with multiple primaries had low-level mosaicism in normal tissues and somatic second-hits affecting the unmethylated allele in all tumors, demonstrating causation. In the population-based cohorts, all 68 cases from the Columbus-area cohort were negative and low-level mosaic constitutional MLH1 methylation was identified in one patient aged 36 years out of 24 from the OCCPI cohort, representing one of six (similar to 17%) patients <50 years and one of 45 patients (similar to 2%) <60 years in the combined cohorts. EC was the first/dual-first cancer in three pa-tients with underlying constitutional MLH1 methylation.Conclusions. A correct diagnosis at first presentation of cancer is important as it will significantly alter clinical management. Screening for constitutional MLH1 methylation is warranted in patients with early-onset EC or syn-chronous/metachronous tumors (any age) displaying MLH1 methylation.(c) 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/). |
Note: | Reproducció del document publicat a: https://doi.org/10.1016/j.ygyno.2023.02.017 |
It is part of: | Gynecologic Oncology, 2023, vol. 171, p. 129-140 |
URI: | http://hdl.handle.net/2445/198672 |
Related resource: | https://doi.org/10.1016/j.ygyno.2023.02.017 |
ISSN: | 0090-8258 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PIIS009082582300094X.pdf | 4.12 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License